{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:19:45Z","timestamp":1776259185824,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shenzhen Engineering Research Center","award":["XMHT20220104016"],"award-info":[{"award-number":["XMHT20220104016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-025-19064-0","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:18:47Z","timestamp":1770380327000},"page":"4858-4872","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncological Safety of Bladder Preservation in Elderly Patients with Muscle-Invasive Bladder Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Irfan","family":"Mehmud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"1","key":"19064_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin."},{"issue":"10","key":"19064_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"7","key":"19064_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.trecan.2019.05.011","volume":"5","author":"R Ghandour","year":"2019","unstructured":"Ghandour R, Singla N, Lotan Y. Treatment options and outcomes in nonmetastatic muscle invasive bladder cancer. Trends Cancer. 2019;5(7):426\u201339.","journal-title":"Trends Cancer."},{"issue":"10061","key":"19064_CR4","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W, et al. Bladder cancer. Lancet. 2016;388(10061):2796\u2013810.","journal-title":"Lancet."},{"issue":"5","key":"19064_CR5","first-page":"614","volume":"23","author":"RM Douglas","year":"1996","unstructured":"Douglas RM, Kaufman DS, Zietman AL, Althausen AF, Heney NM, Shipley WU. Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer. Semin Oncol. 1996;23(5):614\u201320.","journal-title":"Semin Oncol."},{"issue":"3","key":"19064_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11864-016-0390-8","volume":"17","author":"OM El-Taji","year":"2016","unstructured":"El-Taji OM, Alam S, Hussain SA. Bladder sparing approaches for muscle-invasive bladder cancers. Curr Treat Options Oncol. 2016;17(3):15.","journal-title":"Curr Treat Options Oncol."},{"issue":"4","key":"19064_CR7","first-page":"225","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"19064_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(SICI)1098-2388(199709\/10)13:5<291::AID-SSU2>3.0.CO;2-8","volume":"13","author":"SL Johansson","year":"1997","unstructured":"Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol. 1997;13(5):291\u20138.","journal-title":"Semin Surg Oncol."},{"issue":"1","key":"19064_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12957-018-1497-0","volume":"16","author":"PL Shen","year":"2018","unstructured":"Shen PL, Lin ME, Hong YK, He XJ. Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies. World J Surg Oncol. 2018;16(1):197.","journal-title":"World J Surg Oncol."},{"key":"19064_CR10","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372:n71.","journal-title":"BMJ (Clin Res Ed)."},{"key":"19064_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ (Clin Res Ed). 2017;358:j4008.","journal-title":"BMJ (Clin Res Ed)."},{"key":"19064_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol."},{"issue":"6","key":"19064_CR13","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785\u2013805.","journal-title":"Stat Methods Med Res."},{"key":"19064_CR14","unstructured":"Wells G SB, O\u2019Connell D, Peterson J, Welch V, Losos M. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Accessed 2021 [Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"5","key":"19064_CR15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1097\/JS9.0000000000000389","volume":"109","author":"L Gan","year":"2023","unstructured":"Gan L, Peng L, Meng C, Zheng L, Zeng Z, Ge S, et al. The role of laparoscopic adrenalectomy in the treatment of large pheochromocytomas (>6 cm): a meta-analysis and systematic review. Int J Surg (London, England). 2023;109(5):1459\u201369.","journal-title":"Int J Surg (London, England)."},{"issue":"11","key":"19064_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med."},{"issue":"7109","key":"19064_CR17","first-page":"629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997;315(7109):629\u201334.","journal-title":"BMJ (Clin Res Ed)."},{"issue":"4","key":"19064_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/ijo.2013.2058","volume":"43","author":"H Azuma","year":"2013","unstructured":"Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Uehara H, et al. A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen). Int J Oncol. 2013;43(4):1087\u201394.","journal-title":"Int J Oncol."},{"issue":"8","key":"19064_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/0284186X.2022.2101381","volume":"61","author":"N Verschoor","year":"2022","unstructured":"Verschoor N, Heemsbergen WD, Boormans JL, Franckena M. Bladder-sparing (chemo)radiotherapy in elderly patients with muscle-invasive bladder cancer: a retrospective cohort study. Acta Oncologica. 2022;61(8):1019\u201325.","journal-title":"Acta Oncologica."},{"issue":"10","key":"19064_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/jamasurg.2018.1680","volume":"153","author":"SB Williams","year":"2018","unstructured":"Williams SB, Shan Y, Jazzar U, Mehta HB, Baillargeon JG, Huo J, et al. Comparing survival outcomes and costs associated with radical cystectomy and trimodal therapy for older adults with muscle-invasive bladder cancer. JAMA Surg. 2018;153(10):881\u20139.","journal-title":"JAMA Surg."},{"issue":"5","key":"19064_CR21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1590\/S1677-5538.IBJU.2013.05.03","volume":"39","author":"T Martini","year":"2013","unstructured":"Martini T, Mayr R, Wehrberger C, Dechet C, Lodde M, Palermo S, et al. Comparison of radical cystectomy with conservative treatment in geriatric (\u2265 80) patients with muscle-invasive bladder cancer. International Braz J Urol. 2013;39(5):622\u201330.","journal-title":"International Braz J Urol."},{"issue":"8","key":"19064_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jcma.2015.05.003","volume":"78","author":"CL Chen","year":"2015","unstructured":"Chen CL, Liu CY, Cha TL, Hsu CY, Chou YC, Wu ST, et al. Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer? J Chin Med Assoc. 2015;78(8):469\u201374.","journal-title":"J Chin Med Assoc."},{"issue":"4","key":"19064_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/0284186X.2017.1369565","volume":"57","author":"J Boustani","year":"2018","unstructured":"Boustani J, Bertaut A, Galsky MD, Rosenberg JE, Bellmunt J, Powles T, et al. Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators. Acta Oncologica. 2018;57(4):491\u20137.","journal-title":"Acta Oncologica."},{"key":"19064_CR24","doi-asserted-by":"crossref","unstructured":"Horlemann B, W\u00fcrnschimmel C, Hoeh B, Sorce G, Chierigo F, Flammia RS, et al. 2022 Radical cystectomy vs. radiotherapy in urothelial bladder cancer in elderly and very elderly patients. Clin Genitourin Cancer. 20 1 93.e1-.e9.","DOI":"10.1016\/j.clgc.2021.08.003"},{"key":"19064_CR25","unstructured":"Nan X, Wang S, Shi Y, Xu R. 2021 Influence of sequential chemoradiotherapy after TURBT on the survival time and quality of life of elderly patients with MIBC. Mod Oncol. 4165-8."},{"issue":"12","key":"19064_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1586\/14737140.2014.953938","volume":"14","author":"S Hafeez","year":"2014","unstructured":"Hafeez S, Huddart R. Selective organ preservation for the treatment of muscle-invasive transitional cell carcinoma of the bladder: a review of current and future perspectives. Expert Rev Anticancer Ther. 2014;14(12):1429\u201343.","journal-title":"Expert Rev Anticancer Ther."},{"issue":"1","key":"19064_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comp\u00e9rat EM, Cowan NC, Gakis G, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol."},{"issue":"10","key":"19064_CR28","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.6004\/jnccn.2017.0156","volume":"15","author":"PE Spiess","year":"2017","unstructured":"Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, et al. Bladder Cancer Version 5 2017 NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw JNCCN. 2017;15(10):1240\u201367.","journal-title":"J Natl Compr Cancer Netw JNCCN."},{"issue":"2","key":"19064_CR29","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1464-410X.1982.tb13537.x","volume":"54","author":"HJ Bloom","year":"1982","unstructured":"Bloom HJ, Hendry WF, Wallace DM, Skeet RG. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol. 1982;54(2):136\u201351.","journal-title":"Br J Urol."},{"key":"19064_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/21681805.1991.12068888","volume":"138","author":"A Sell","year":"1991","unstructured":"Sell A, Jakobsen A, Nerstr\u00f8m B, S\u00f8rensen BL, Steven K, Barlebo H. Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. Scand J Urol Nephrol Supplementum. 1991;138:193\u2013201.","journal-title":"Scand J Urol Nephrol Supplementum."},{"issue":"16","key":"19064_CR31","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","volume":"366","author":"ND James","year":"2012","unstructured":"James ND, Hussain SA, Hall E, Jenkins P, Tremlett J, Rawlings C, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012;366(16):1477\u201388.","journal-title":"N Engl J Med."},{"issue":"2","key":"19064_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.juro.2006.09.027","volume":"177","author":"HW Herr","year":"2007","unstructured":"Herr HW, Dotan Z, Donat SM, Bajorin DF. Defining optimal therapy for muscle invasive bladder cancer. J Urol. 2007;177(2):437\u201343.","journal-title":"J Urol."},{"issue":"4","key":"19064_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.eururo.2017.04.028","volume":"72","author":"GS Kulkarni","year":"2017","unstructured":"Kulkarni GS, Klaassen Z. Trimodal therapy is inferior to radical cystectomy for muscle-invasive bladder cancer using population-level data: is there evidence in the (lack of) details? Eur Urol. 2017;72(4):488\u20139.","journal-title":"Eur Urol."},{"issue":"1","key":"19064_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1464-410X.2012.11762.x","volume":"112","author":"ZL Smith","year":"2013","unstructured":"Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int. 2013;112(1):13\u201325.","journal-title":"BJU Int."},{"issue":"12","key":"19064_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11934-018-0859-z","volume":"19","author":"A El-Achkar","year":"2018","unstructured":"El-Achkar A, Souhami L, Kassouf W. Bladder preservation therapy: review of literature and future directions of trimodal therapy. Curr Urol Rep. 2018;19(12):108.","journal-title":"Curr Urol Rep."},{"key":"19064_CR36","doi-asserted-by":"publisher","first-page":"564779","DOI":"10.3389\/fonc.2020.564779","volume":"10","author":"H Ding","year":"2020","unstructured":"Ding H, Fan N, Ning Z, Ma D. Trimodal therapy vs radical cystectomy for muscle-invasive bladder cancer a meta-analysis. Front Oncol. 2020;10:564779.","journal-title":"Front Oncol."},{"issue":"12","key":"19064_CR37","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00345-018-2384-6","volume":"36","author":"HA Garc\u00eda-Perdomo","year":"2018","unstructured":"Garc\u00eda-Perdomo HA, Montes-Cardona CE, Guacheta M, Castillo DF, Reis LO. Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis. World J Urol. 2018;36(12):1997\u20132008.","journal-title":"World J Urol."},{"issue":"1","key":"19064_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12957-023-03161-z","volume":"21","author":"X Su","year":"2023","unstructured":"Su X, Dong C, Liao W, Liu W. Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis. World J Surg Oncol. 2023;21(1):271.","journal-title":"World J Surg Oncol."},{"key":"19064_CR39","doi-asserted-by":"publisher","first-page":"1276746","DOI":"10.3389\/fsurg.2023.1276746","volume":"10","author":"AR Al-Qudimat","year":"2023","unstructured":"Al-Qudimat AR, Singh K, Ojha LK, Moustafa DA, Elaarag M, Al-Zoubi RM, et al. Comparing trimodal therapy with radical cystectomy in muscle-invasive bladder cancer: an updated meta-analysis. Front Surg. 2023;10:1276746.","journal-title":"Front Surg."},{"issue":"9","key":"19064_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040284","volume":"4","author":"GS Kulkarni","year":"2007","unstructured":"Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Optimal management of high-risk T1G3 bladder cancer: a decision analysis. PLoS Med. 2007;4(9):e284.","journal-title":"PLoS Med."},{"issue":"8","key":"19064_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1046\/j.1442-2042.2003.00657.x","volume":"10","author":"T Matsuda","year":"2003","unstructured":"Matsuda T, Aptel I, Exbrayat C, Grosclaude P. Determinants of quality of life of bladder cancer survivors five years after treatment in France. Int J Urol. 2003;10(8):423\u20139.","journal-title":"Int J Urol."},{"issue":"8","key":"19064_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrurol.2014.151","volume":"11","author":"RA Modh","year":"2014","unstructured":"Modh RA, Mulhall JP, Gilbert SM. Sexual dysfunction after cystectomy and urinary diversion. Nat Rev Urol. 2014;11(8):445\u201353.","journal-title":"Nat Rev Urol."},{"key":"19064_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110038","volume":"190","author":"G Francolini","year":"2024","unstructured":"Francolini G, Ghoshal A, Caini S, Piazzini T, Becherini C, Detti B, et al. Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2024;190:110038.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-19064-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-19064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:25:55Z","timestamp":1776255955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-19064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19064"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-19064-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by the Shenzhen Engineering Research Center; project approval number: XMHT20220104016.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no financial conflict of interest with regard to the content of this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}